{"cluster": 68, "subcluster": 4, "abstract_summ": "DISCUSSION We have shown that Fundaci\u00f3 ACE model of care has been able to successfully adapt to a health and social critical situation as COVID-19 pandemic.In addition, the pandemic has impacted ALS clinical trials by impairing the ability to obtain measurements for trial eligibility, to monitor safety and efficacy outcomes, and to dispense study drug, as these also often rely on in\u2010person visits.Delivering care to this vulnerable population amidst the COVID-19 pandemic has represented a major challenge to our institution.OBJECTIVE To investigate the effects of COVID-19 pandemic on patients' perceptions of hardship in obtaining their drugs and if this pandemic and the social restrictions in response to that has resulted in any changes in their seizure control status.The current COVID-19 pandemic could be considered as a major shock to a nation that has already been under significant pressure (i.e., Iran).Coronavirus disease 2019 has created unprecedented challenges for amyotrophic lateral sclerosis (ALS) clinical care and research in the United States.", "title_summ": "Impacts of the COVID-19 pandemic on Iranian patients with epilepsy.Amyotrophic lateral sclerosis care and research in the United States during the COVID\u201019 pandemic: Challenges and opportunities: Experience at Fundaci\u00f3 ACE in Barcelona, Spain.Dementia Care in Times of COVID-19", "title_abstract_phrases": "DISCUSSION We have shown that Fundaci\u00f3 ACE model of care has been able to successfully adapt to a health and social critical situation as COVID-19 pandemic.The current COVID-19 pandemic could be considered as a major shock to a nation that has already been under significant pressure (i.e., Iran).Amyotrophic lateral sclerosis care and research in the United States during the COVID\u201019 pandemic: Challenges and opportunitiesCoronavirus disease 2019 has created unprecedented challenges for amyotrophic lateral sclerosis (ALS) clinical care and research in the United States.Impacts of the COVID-19 pandemic on Iranian patients with epilepsy.Delivering care to this vulnerable population amidst the COVID-19 pandemic has represented a major challenge to our institution.In addition, the pandemic has impacted ALS clinical trials by impairing the ability to obtain measurements for trial eligibility, to monitor safety and efficacy outcomes, and to dispense study drug, as these also often rely on in\u2010person visits."}